Fisher & Paykel Healthcare (ASX:FPH, NZE:FPH) now expects a fiscal 2027 net profit after tax (NPAT) of about NZ$525 million to NZ$565 million, and operating revenue of about NZ$2.47 billion to NZ$2.57 billion, according to a Friday filing with the Australian and New Zealand bourses.

The new guidance is up from a previous forecast for NPAT of NZ$500 million to NZ$550 million and operating revenue of NZ$2.45 billion to NZ$2.57 billion.

For the first half of fiscal 2027, which ends Sept. 30, the company expects NPAT of about NZ$280 million and revenue of NZ$1.24 billion, per the filing.

Fisher & Paykel said the fiscal first half and fiscal year NPAT outlook incorporates NZ$23 million in US tariff refunds.